PL
JBIO

Parkwood LLC’s Jade Biosciences JBIO Stock Holding History

Parkwood LLC’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-528
Closed -$31K – 89
2024
Q2 		$31K Buy
528
+21
+4% +$13.9K ﹤0.01% 125
2024
Q1 		$524K Buy
507
+56
+12% +$42.8K 0.05% 164
2023
Q4 		$357K Sell
451
-139
-24% -$70.8K 0.04% 112
2023
Q3 		$280K Sell
590
-62
-10% -$33.6K 0.03% 116
2023
Q2 		$392K Sell
652
-87
-12% -$55.6K 0.07% 113
2023
Q1 		$522K Buy
739
+152
+26% +$126K 0.07% 113
2022
Q4 		$602K Sell
587
-23
-4% -$16.7K 0.09% 106
2022
Q3 		$354K Sell
610
-316
-34% -$211K 0.05% 126
2022
Q2 		$507K Buy
+926
New +$442K 0.09% 110
2022
Q1 		– Sell
-1,062
Closed -$438K – 132
2021
Q4 		$438K Sell
1,062
-311
-23% -$157K 0.07% 99
2021
Q3 		$1.01M Buy
+1,373
New +$769K 0.12% 94

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return